DOCSLIB.ORG

Briefing to Care Homes and Domiciliary Care Providers During COVID-19 Will Maimaris, Director of Public Health

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Briefing to Care Homes and Domiciliary Care Providers During COVID-19 Will Maimaris, Director of Public Health 11/05/21 Briefing to care homes and domiciliary care providers during COVID-19 Will Maimaris, Director of Public Health This is briefing number 57 from Haringey’s Director of Public Health, in collaboration with our Clinical Commissioning Group. Latest updates Update on COVID-19 cases Overall, we have seen a decline in the number of infections reported across London this week, and cases in the community remain low. In Haringey, our weekly incidence rate for all ages has increased to 16.0 per 100,000 and to 2.6 per 100,000 for ages 60+. COVID-19 associated hospital admission rates have also fallen across North London. In the last week, no new cases have been reported in Haringey care settings, however, we continue to closely monitor the situation. Please continue to ensure you and your staff are following Public Health England guidance relating to Personal Protective Equipment (PPE) to limit the spread of COVID-19: • for all care settings: Personal Protective Equipment (PPE) illustrated guide for community and social care settings • for care homes: COVID-19: how to work safely in care homes • for domiciliary care: COVID-19: how to work safely in domiciliary care in England • care home and home care providers can use the PPE Portal to order and receive critical coronavirus (COVID-19) personal protective equipment (PPE). Further resources can be found in our COVID-19 support directory at the end of this document. If you suspect a case of COVID-19 in your care setting, please immediately inform the London Coronavirus Response Cell (LCRC) on 0300 303 0450 or email [email protected], and also notify Haringey Public Health team at [email protected]. Any member of social care staff who develops symptoms should immediately self-isolate and order a test. 11/05/21 Oxford/AstraZeneca Vaccine Update The Joint Committee for Vaccinations and Immunisations (JCVI) has updated its guidance on vaccine usage in adults aged under 40. On reviewing the latest data, the JCVI advises as a precaution, that it is preferable for people under the age of 40 to receive either Pfizer/BioNTech or Moderna vaccine. This is due to reports of an extremely rare blood clotting problem affecting a small number of people who have had the Oxford/AstraZeneca vaccine ➢ People aged 40 or over and those with other health conditions should still receive any of the available COVID vaccines when offered. The benefits of being vaccinated with the AstraZeneca vaccine in this age group continue to outweigh any risk of clotting problems. ➢ There are currently no safety concerns of blood clots following second dose of AZ vaccine, and if you are aged under 40 and received AZ with no issues, you can have AZ as your second dose. The update has been informed by the current vaccine supply and rate of infection in the UK, which means this precautionary step can be taken whilst ensuring all adults are offered a vaccine by the end of July. Further information • The NHS UK COVID Vaccination site has been updated to include details about vaccination and blood clotting. • An information leaflet on COVID-19 vaccination and blood clotting has been produced by Public Health England. COVID-19 vaccine update More than 35 million people in the UK have now received their first dose of a COVID-19 vaccine, while 17 million people have had both doses. Within Haringey, 87% of care home residents and 73% of care staff have been vaccinated. We are very pleased to see the uptake among Haringey care homes is high, and we continue to work with care home managers to increase uptake among staff. Vaccinating care home staff and residents to protect them from COVID-19 is a national priority. By providing vaccinations, your care home will be playing its part in protecting all residents and staff from catching and spreading the virus, as well as helping the national response to the pandemic. 11/05/21 New research suggests that one dose of either Oxford/AZ or Pfizer vaccine can prevent transmission of COVID-19 to other individuals by up to 50%. This evidence is reassuring and shows the vaccine can help keep you, your colleagues, and your service users safe. Remember: ➢ Vaccines are our way out of the pandemic. ➢ Strict approval processes mean that all approved vaccines are safe and are our best defence against the virus. ➢ The vaccine cannot give you COVID-19 infection and will reduce your chance of becoming seriously ill. ➢ For every 20 vaccinations in the care home resident cohort, one death is potentially preventable. COVID vaccine booking arrangements for care staff – first dose appointments The National Booking System has reopened to health and social care workers. Care staff can use the National Booking Service to book a specific appointment at a wide range of vaccine centres in north London. Staff eligibility will be checked so please make sure you bring your work or photo ID and NHS number if you have it to the appointments. Staff can book a first dose online at www.nhs.uk/covid-vaccination or by calling 119. There are also local arrangements by NCL for social care and NHS staff to access vaccines, including drop in vaccination sites for staff of all ages. Please check the NCL Vaccination web link for more information. Staff who are under 40 should visit the NCL webpage to book an appointment at the Islington Business Design vaccine centre as this provides the Moderna vaccine. More information on why staff under 40 are offered an alternative to the AZ / Oxford vaccine is available here. We want to reassure all those who are eligible, that it is not too late to get the first dose of their COVID-19 vaccine. 11/05/21 COVID Vaccination for staff – second dose appointments Health and social care staff who were vaccinated through local authority arrangements are being encouraged to book their second vaccination dose. Staff should be contacted within 11 weeks of the first vaccination to book an appointment for a second dose. We will endeavour to offer the second vaccine dose at the same location as the first vaccination. If staff have not been contacted within 10-11 weeks, please consider the following: • If they have received the AstraZeneca vaccination (first dose) individuals are able to call 119 or visit NHS: Book Coronavirus Vaccination to book or rearrange their appointment. • If they had a Pfizer vaccination (first dose) and have not been contacted within 10- 11 weeks of their first vaccination to book an appointment for a second dose, individuals can contact [email protected]. They will need to include details of the date and location of the first vaccination. COVID Vaccination sessions for staff The public health team in Haringey continue to offer extensive support for staff who are hesitant about having the vaccine. We can offer the following: • COVID vaccine webinars with your staff • Attend staff meetings to answer questions about the vaccine • One-to-one sessions with a doctor working in public health for staff who may have personal concerns about the vaccine If you have any staff who would be interested in this initiative, or would like to request a webinar with your staff, please email [email protected] or [email protected] for further information. 11/05/21 COVID Vaccine Champions in health and social care London Borough of Haringey and Public Health team are looking to recruit COVID Vaccine Champions amongst staff working within adult social care settings in Haringey. The main role of this vaccine champion will be to initiate conversations with colleagues, service users and their families with confidence, understanding and empathy, to identify and help resolve any barriers to vaccination. The nominated COVID champion will be given the necessary training including induction, resources including FAQ packs, and practical support on how best to support their colleagues, clients and their families. Upcoming training sessions. • Wednesday 12th May, 7.30 - 9pm. Click here to sign up on Eventbrite • Thursday 20th May, 1-2pm. Please email [email protected] if you would like to sign up for this session. All participants will be issued a certificate of participation, which can be used as evidence of leadership/teamwork and will be renumerated for attending training sessions. Please share this advert with your staff and submit an email nominating 1 or 2 staff members for the position to [email protected]. COVID-19 vaccines and fertility One of the most frequently asked questions from care workers is whether the vaccine affects fertility. There is no evidence of this. The British Fertility Society has produced this leaflet to provide helpful information to share with your colleagues for their peace of mind. Meanwhile, further reassurance is provided in this joint statement from the Royal Colleges of Midwives, Obstetrics and Gynaecology. There is also a video produced by Public Health England on the COVID vaccines and fertility. Pregnancy and COVID Vaccination – new resources Recently, the Joint Committee on Vaccination and Immunisation (JCVI) issued new advice confirming that all pregnant women should be offered the COVID-19 vaccine at the same time as the rest of the population, based on their age and clinical risk group. 11/05/21 There is a set of FAQs available if you or your staff have any further questions. Public Health England has also issued an updated leaflet. Visiting restrictions eased in care homes As part of step 3 of the roadmap, care home residents will be able to have more named visitors and more opportunities to make visits out with no need to self-isolate when they return.
Load more

Recommended publications
  • Randomised Trial to Compare the Immunogenicity and Safety of a CRM Or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenag
    Title Page Randomised trial to compare the immunogenicity and safety of a CRM or TT 1 2 conjugated quadrivalent meningococcal vaccine in teenagers who received a 3 4 5 CRM or TT conjugated serogroup C vaccine at preschool age 6 7 8 9 1,2 1,3 1 10 David A. Ishola , FFPH; Nick Andrews , PhD; Pauline Waight , BSc; Chee-Fu 11 12 Yung1,6, FFPH; Jo Southern1, PhD; Xilian Bai4, PhD; Helen Findlow4, PhD; Mary 13 14 5 5 5 4 15 Matheson , PhD; Anna England , MSc; Bassam Hallis , PhD; Jamie Findlow , PhD; 16 4 1 17 Ray Borrow , PhD; Elizabeth Miller , FRCPath. 18 19 1. Immunisation Department, Public Health England (PHE), London, UK 20 21 22 2. Department of Infection and Population Health, University College London, 23 24 London, UK 25 26 27 3. Statistics, Modelling, and Economics Department, PHE London, UK 28 29 4. Vaccine Evaluation Unit, PHE, Manchester Medical Microbiology Partnership, 30 31 32 Manchester Royal Infirmary, Manchester, UK 33 34 5. Microbiology Services, PHE, Porton Down, Salisbury, UK 35 36 6. Department of Clinical Epidemiology, Communicable Disease Centre, Tan Tock 37 38 39 Seng Hospital, Singapore. 40 41 Correspondence: David Ishola, University College London, Department of Infection 42 43 44 and Population Health, 222 Euston Road, London NW1 2DA, UK. Tel: +44 45 46 (0)7946412701. Fax: +44 (0)20 83277404. E-mail: [email protected] 47 48 49 Address for reprints: Not applicable (reprints not available). 50 51 Key words: Meningococcal, vaccine, teenagers, antibody, randomised trial 52 53 54 Abbreviated title: Teenage MenACWY booster vaccination: Randomised trial 55 56 Running head title: Teenage MenACWY booster vaccination 57 58 59 60 61 62 1 63 64 65 CONFLICTS OF INTEREST AND SOURCE OF FUNDING: 1 2 Funding and support: This report is independent research commissioned and 3 4 5 funded by the UK Department of Health Policy Research Programme (National 6 7 Vaccine Evaluation Consortium, 039/0031).
    [Show full text]
  • The NHS's Role in the Public's Health
    The NHS’s role in the public’s health A report from the NHS Future Forum Workstream members Vicky Bailey ‐ Chair, NHS’s role in the public’s health group Chief Operating Officer, Principia Rushcliffe Clinical Commissioning Group Ash Soni ‐ Chair, NHS’s role in the public’s health group Community Pharmacist; Clinical Network Lead, NHS Lambeth Dr Charles Alessi Senior GP Partner, The Churchill Practice Dr Frank Atherton President, Association of Directors of Public Health; Director of Public Health, North Lancashire Cluster Ratna Dutt Chief Executive, Race Equality Foundation Paul Farmer Chief Executive, Mind Moira Gibb Chief Executive, London Borough of Camden; Chair, Social Work Task Force Chris Long Chief Executive, Humber Cluster Claire Marshall Head of Professions, Heatherwood and Wexham Park Hospitals NHS Foundation Trust Dr Tim Riley Chief Executive, Wellstate Group Ltd Tom Riordan Chief Executive, Leeds City Council Dr Robina Shah Chair, Stockport NHS Foundation Trust Professor Jimmy Steele Head of School and Professor of Oral Health Services Research, School of Dental Sciences, Newcastle University Gill Walton Director of Midwifery, Portsmouth Hospitals NHS Trust Contents Contents.........................................................................................................................2 Foreword........................................................................................................................3 Terms used in this report...............................................................................5
    [Show full text]
  • COVID-19 Vaccination Programme: Information for Healthcare Practitioners
    COVID-19 vaccination programme Information for healthcare practitioners Republished 6 August 2021 Version 3.10 1 COVID-19 vaccination programme: Information for healthcare practitioners Document information This document was originally published provisionally, ahead of authorisation of any COVID-19 vaccine in the UK, to provide information to those involved in the COVID-19 national vaccination programme before it began in December 2020. Following authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency being given to the COVID-19 Vaccine Pfizer BioNTech on 2 December 2020, the COVID-19 Vaccine AstraZeneca on 30 December 2020 and the COVID-19 Vaccine Moderna on 8 January 2021, this document has been updated to provide specific information about the storage and preparation of these vaccines. Information about any other COVID-19 vaccines which are given regulatory approval will be added when this occurs. The information in this document was correct at time of publication. As COVID-19 is an evolving disease, much is still being learned about both the disease and the vaccines which have been developed to prevent it. For this reason, some information may change. Updates will be made to this document as new information becomes available. Please use the online version to ensure you are accessing the latest version. 2 COVID-19 vaccination programme: Information for healthcare practitioners Document revision information Version Details Date number 1.0 Document created 27 November 2020 2.0 Vaccine specific information about the COVID-19 mRNA 4 Vaccine BNT162b2 (Pfizer BioNTech) added December 2020 2.1 1.
    [Show full text]
  • Research Strategy 2015-2018 Public Health Wales Research Strategy 2015–2018
    Research Strategy 2015-2018 Public Health Wales Research Strategy 2015–2018 01 ForewordText Public health covers a broad range of activities. These include primary prevention, surveillance and early detection of disease, control and management of communicable diseases and environmental threats, improving healthcare quality, informing policy and implementing interventions and programmes to improve population health and wellbeing. The public health challenges in Wales are similar Public Health Wales’ Integrated Medium Term Plan Integration between to many post-industrial societies, with an ageing for 2015-2018 clearly identifies a suite of priority population and high prevalence of chronic conditions areas for action. Integration between public health public health research, such as diabetes and cardiovascular disease. Health research, policy and practice will be essential for us policy and practice will be inequalities persist in many areas, and the gap in to drive forward improvements in population health healthy life expectancy between the most and least and wellbeing. We therefore welcome this research essential for us to drive deprived areas is 18 years. For example, 25% of strategy, which aims to develop research capacity forward improvements children aged four to five are overweight or obese, and capability within Public Health Wales. Successful while 22% of adults are obese, with higher prevalence implementation of this strategy over the next three in population health and in more deprived areas. Similar profiles exist for years
    [Show full text]
  • Annual Report and Accounts 2018/19
    Annual report and accounts 2018/19 HC 2479 Care Quality Commission Annual report and accounts 2018/19 Presented to Parliament pursuant to paragraph 10(4) of Schedule 1 of the Health and Social Care Act 2008. Ordered by the House of Commons to be printed on 24 July 2019. HC 2479 © Care Quality Commission copyright 2019 The text of this document (this excludes, where present, the Royal Arms and all departmental or agency logos) may be reproduced free of charge in any format or medium provided that it is reproduced accurately and not in a misleading context. The material must be acknowledged as Care Quality Commission copyright and the document title specified. Where third party material has been identified, permission from the respective copyright holder must be sought. Any enquiries related to this publication should be sent to us at [email protected]. This publication is available at www.gov.uk/official-documents. ISBN 978-1-5286-1521-1 ID CCS0619531556 07/19 Printed on paper containing 75% recycled fibre content minimum. Printed in the UK by APS Group on behalf of the Controller of Her Majesty’s Stationery Office. Contents Who we are and what we do 2 Performance report 4 Foreword 5 Performance summary 7 Performance analysis 11 Accountability report 51 Corporate governance report 52 Remuneration and people report 68 Parliamentary accountability and audit report 82 Certificate and report of the Comptroller and Auditor General 84 to the Houses of Parliament Financial statements 87 Statement of Comprehensive Net Expenditure 88 Statement of Financial Position 89 Statement of Cash Flows 90 Statement of Changes in Taxpayers’ Equity 91 Notes to the financial statements 92 Who we are and what we do Who we are and what we do Who we are: The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England.
    [Show full text]
  • The State of Health Care and Adult Social Care in England 2015/16 @Carequalitycomm
    Care Quality Commission Care The state of health How to contact us in England and adult social care of health care The state care and adult social Call us on 03000 616161 care in England Email us at [email protected] Look at our website www.cqc.org.uk 2015/16 Write to us at Care Quality Commission Citygate Gallowgate Newcastle upon Tyne NE1 4PA 2015/16 Follow us on Twitter @CareQualityComm Read the summary and download this report in other formats at www.cqc.org.uk/stateofcare Scan this code on your phone to visit the site now. Please contact us if you would like this report in another language or format. CQC-347-410-102016 Care Quality Commission The state of health care and adult social care in England 2015/16 Presented to Parliament pursuant to section 83(4)(a) of the Health and Social Care Act 2008. Ordered by the House of Commons to be printed on 12 October 2016. HC 706 © Care Quality Commission 2016 The text of this document (this excludes, where present, the Royal Arms and all departmental and agency logos) may be reproduced free of charge in any format or medium providing that it is reproduced accurately and not in a misleading context. The material must be acknowledged as Care Quality Commission copyright and the document title specified. Where third party material has been identified, permission from the respective copyright holder must be sought. Any enquiries regarding this publication should be sent to us at [email protected] This publication is available at https://www.gov.uk/government/publications Print: ISBN 9781474137553 Web: ISBN 9781474137560 Printed in the UK by the Williams Lea Group on behalf of the Controller of Her Majesty’s Stationery Office.
    [Show full text]
  • A Guide to Community-Centred Approaches for Health and Wellbeing
    A guide to community-centred approaches for health and wellbeing Full report Community-centred approaches for health and wellbeing About Public Health England Public Health England exists to protect and improve the nation's health and wellbeing, and reduce health inequalities. It does this through world-class science, knowledge and intelligence, advocacy, partnerships and the delivery of specialist public health services. PHE is an operationally autonomous executive agency of the Department of Health. Public Health England Wellington House 133-155 Waterloo Road London SE1 8UG Tel: 020 7654 8000 www.gov.uk/phe Twitter: @PHE_uk Facebook: www.facebook.com/PublicHealthEngland Prepared by: Professor Jane South Supported by: Jude Stansfield, Pritti Mehta and advisory group: Anne Brice, Ann Marie Connolly, Catherine Davies, Gregor Henderson, Paul Johnstone (PHE), Olivia Butterworth, Luke O’Shea, Giles Wilmore (NHS England). Also Dave Buck, James Thomas, Ginny Brunton. Anne-Marie Bagnall and Kris Southby, Leeds Beckett University, undertook a scoping review for this publication. © Crown copyright 2015 You may re-use this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence v3.0. To view this licence, visit OGL or email [email protected]. Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. Any enquiries regarding this publication should be sent to [email protected]. Published February 2015 PHE publications gateway number: 2014711 2 Community-centred approaches for health and wellbeing Contents About Public Health England 2 Foreword 4 Executive summary 5 Introduction 7 Why work with communities? 8 Communities as building blocks for health 11 A family of community-centred approaches 15 Health outcomes and evidence 31 Conclusion 36 Appendix 1.
    [Show full text]
  • UK Field Epidemiology Training Programme Prospectus 2021 the UK Field Epidemiology Training Programme
    UK Field Epidemiology Training Programme Prospectus 2021 The UK Field Epidemiology Training Programme The Field Epidemiology Training Programme (FETP) is a full-time two-year fellowship programme, which provides training and practical experience in intervention epidemiology and aims to develop specialist field On-the-job epidemiology skills. Training is provided mainly through on-the-job service provision and learning activities, but at least ten percent of time will be dedicated to formally taught training courses. The programme currently covers England, Wales and Northern Ireland. Conferences Courses There are 12 training sites. The majority are within Field Service (FS) teams. These teams are part of a nationally coordinated and managed service that is geographically dispersed with specialist field epidemiology teams spread across England. In addition, there are sites in National Centres (NC) and Health Protections Teams (HPT), who provide specialist public health advice and operational support to NHS/local authorities etc., and in the Centre for Radiation, Chemicals and Environmental Hazards (CRCE). Belfast Newcastle NC FS Liverpool Leeds FS FS Birmingham Nottingham FS FS Cardiff Cambridge NC FS/HPT Bristol London FS FS Oxford London CRCE/HPT NC 2 UK FETP goals 1. To strengthen capacity and provision of public health epidemiology 2. To develop a network of skilled field epidemiologists with a shared sense of purpose, working to common standards across the UK and Europe 3. To raise the profile of field epidemiology and embed this into everyday health protection practice 4. To support PHE’s global public health workplan through provision of fellows and staff to support international response and capacity building Graduation Criteria These are the minimum criteria to pass the programme but the fellowship has flexibility and time to support multiple projects in different areas, based on the needs of individual fellows.
    [Show full text]
  • Health Inequalities Resources
    Health Inequalities Resources This is a resource to support teams in meeting their health inequalities duties by signposting you to key publically available resources. This is not intended to be a definitive list. However, we are keen to update this regularly. Please do therefore let us know if you have a suggestion for any additional resources to be added? Please email these to [email protected] NHS England/ Public Health England (PHE)/ other – general resources Heath Inequalities Intervention Toolkit (Spearhead): http://www.lho.org.uk/LHO_Topics/Analytic_Tools/HealthInequalitiesInterventionToolkit.aspx PHE Longer Lives website: http://healthierlives.phe.org.uk/ Centre for Local Economic Strategies/ PHE - Due North: The report of the Inquiry on Health Equity for the North: http://www.cles.org.uk/news/inquiry-publishes-due-north-report-on-health-equity/ PHE National conversation on Health Inequalities: Report of event held on 25th June 2014: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/356982/National_ Conversations_Report_19_Sept.pdf NHS England Dec 2013 Board paper – Promoting Equality and Tackling Health Inequalities: http://www.england.nhs.uk/wp-content/uploads/2013/12/brd-dec-1.pdf PHE Health Equity Assessment Tool: PHE Priorities - From evidence into action: opportunities to protect and improve the nation’s health: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/366852/PHE_Prior ities.pdf NHS England – Guidance for NHS Commissioners on Equality and Health Inequalities Legal
    [Show full text]
  • How Your Information Is Shared So That This Practice Can Meet Legal
    How your information is shared so that this practice can meet legal requirements The law requires Devonport Health Centre to share information from your medical records in certain circumstances. Information is shared so that the NHS or Public Health England can, for example: plan and manage services; check that the care being provided is safe; prevent infectious diseases from spreading. We will share information with NHS Digital, the Care Quality Commission and local health protection team (or Public Health England) when the law requires us to do so. Please see below for more information. We must also share your information if a court of law orders us to do so. NHS Digital NHS Digital is a national body which has legal responsibilities to collect information about health and social care services. It collects information from across the NHS in England and provides reports on how the NHS is performing. These reports help to plan and improve services to patients. This practice must comply with the law and will send data to NHS Digital, for example, when it is told to do so by the Secretary of State for Health or NHS England under the Health and Social Care Act 2012. More information about NHS Digital and how it uses information can be found at: https://digital.nhs.uk/home NHS Digital sometimes shares names and addresses of patients suspected of committing immigration offences with the Home Office. More information on this can be found here: https://www.gov.uk/government/publications/information-requests- from-the-home-office-to-nhs-digital Care Quality Commission (CQC) The CQC regulates health and social care services to ensure that safe care is provided.
    [Show full text]
  • SARS-Cov-2 Variants of Concern and Variants Under Investigation in England
    SARS-CoV-2 variants of concern and variants under investigation in England Technical briefing 20 6 August 2021 This briefing provides an update on previous briefings up to 23 July 2021 1 SARS-CoV-2 variants of concern and variants under investigation Contents Summary ............................................................................................................................. 3 Published information on variants ................................................................................... 4 Part 1: Surveillance overview .............................................................................................. 5 1.1 Variants under surveillance ....................................................................................... 5 1.2 Sequencing coverage ................................................................................................ 7 1.3 VOC and VUI case numbers, proportion, deaths and case fatality rate ................... 11 1.4 Variant prevalence ................................................................................................... 21 1.5 Antigenic change over time (international) .............................................................. 26 1.6 Secondary attack rates ............................................................................................ 30 1.7 Vaccination .............................................................................................................. 35 1.8 Updates from Variant Technical Group members...................................................
    [Show full text]
  • Sector-Led Improvement Conference Brochure
    Association of the Directors of Public Health Yorkshire and the Humber Sector-led improvement conference brochure Making the link: evidence and practice Friday 17 February 2017, Royal York Hotel, York Programme 9.30 Arrival and registration 10.00 Introduction and housekeeping (Tim Allison, DPH, East Riding of Yorkshire Council) 10.05 Welcome to York from City of York council (Councillor Carol Runciman, Chair of the York Health and Wellbeing Board) 10.15 Keynote presentation: We can solve poverty in the UK (title TBC). Chris Goulden, Deputy Director of Policy and Research, Joseph Rowntree Foundation 11.00 Whole system community-centred approaches for health and wellbeing: evidence into action. Jane South, Professor of Healthy Communities, Leeds Beckett University and Public Health England 11.20 Break 11.45 Parallel sessions: oral abstract presentations 13.00 Lunch and poster presentations 14.00 Parallel sessions: Communities of Improvement, practitioner registration scheme and linking practice and evidence 15.30 Final plenary (Andrew Furber, DPH Wakefield and President, ADsPH) 15.50 Closing remarks (Tim Allison, DPH, East Riding of Yorkshire Council) 16.00 Close Please Tweet using #YHSLI2017 Parallel sessions The morning sessions will feature the oral abstract presentations with the opportunity to attend three sessions. After lunch you will be able to attend two sessions relating to the work of the Communities of Improvement, a workshop focusing on the links between practice and evidence or a workshop on the forthcoming public health practitioner registration programme. The schedule for the sessions can be found at the end of this conference brochure. Poster presentations can be viewed during the coffee and lunch breaks.
    [Show full text]